Elsevier has acquired Researchfish for an undisclosed amount, significantly expanding its capabilities in research impact assessment and evaluation. This corporate acquisition sees Elsevier, a global leader in information and analytics for customers across the health and science sectors, integrate Researchfish's specialized platform into its portfolio.
Researchfish operates a robust platform utilized by funding organizations worldwide to measure the impact of research. The platform tracks over £50 billion in international funding and monitors more than 3.5 million outcomes from over 160,000 research awards. Its comprehensive reporting provides a broader and deeper understanding of research activities, illustrating pathways to impact. This functionality enables organizations to inform future funding strategies and increase opportunities for collaboration. Notable members leveraging Researchfish include the Bill & Melinda Gates Foundation - Grand Challenges Explorations Initiative, Alberta Innovates, Novo Nordisk Fonden, and Wellcome. Researchfish previously joined Interfolio in 2019.
The acquisition is a strategic move for Elsevier, aligning with its mission to support research excellence and decision-making. By purchasing Researchfish, Elsevier enhances its ability to provide granular insights into the societal and economic returns of research investments. The integration of Researchfish's data and tools with Elsevier's existing research intelligence solutions is expected to create powerful synergies, offering a more holistic view of the research landscape.
This combination will empower funders, institutions, and researchers with advanced tools to track, analyze, and demonstrate the value of scientific endeavors. The combined entity aims to provide an even more comprehensive understanding of research impact, facilitating better resource allocation and fostering innovation across the global research ecosystem.